No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients

Thiel, U.; Wawer, A.; Wolf, P.; Badoglio, M.; Santucci, A.; Klingebiel, T.; Basu, O.; Borkhardt, A.; Laws, H.; Kodera, Y.; Yoshimi, A.; Peters, C.; Ladenstein, R.; Pession, A.; Prete, A.; Urban, E.; Schwinger, W.; Bordigoni, P.; Salmon, A.; Diaz, M.; Afanasyev, B.; Lisukov, I.; Morozova, E.; Toren, A.; Bielorai, B.; Korsakas, J.; Fagioli, F.; Caselli, D.; Ehninger, G.; Gruhn, B.; Dirksen, U.; Abdel-Rahman, F.; Aglietta, M.; Mastrodicasa, E.; Torrent, M.; Corradini, P.; Demeocq, F.; Dini, G.; Dreger, P.; Eyrich, M.; Gozdzik, J.; Guilhot, F.; Holler, E.; Koscielniak, E.; Messina, C.; Nachbaur, D.; Sabbatini, R.; Oldani, E.; Ottinger, H.; Ozsahin, H.; Schots, R.; Siena, S.; Stein, J.; Sufliarska, S.; ÜNAL, ALİ; Ussowicz, M.; Schneider, P.; Woessmann, W.; Juergens, H.; Bregni, M.; Burdach, S.

doi:10.1093/annonc/mdq703

No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients

Thiel U., Wawer A., Wolf P., Badoglio M., Santucci A., Klingebiel T., ...Daha Fazla

ANNALS OF ONCOLOGY, cilt.22, sa.7, ss.1614-1621, 2011 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 22 Sayı: 7
Basım Tarihi: 2011
Doi Numarası: 10.1093/annonc/mdq703
Dergi Adı: ANNALS OF ONCOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1614-1621
Anahtar Kelimeler: advanced-stage Ewing tumor, allogeneic stem cell transplantation, graft versus tumor effect, haploidentical stem cell transplantation, reduced, high-intensity conditioning chemotherapy, PERIPHERAL NEUROECTODERMAL TUMORS, TOTAL-BODY IRRADIATION, HIGH-DOSE THERAPY, EUROPEAN INTERGROUP, SARCOMA, BONE, MARROW, GRAFT, TRANSLOCATION, METASTASES
Erciyes Üniversitesi Adresli: Evet

Özet

Background: Outcomes of Ewing tumor (ET) patients treated with allogeneic stem cell transplantation (allo-SCT) were compared regarding the use of reduced-intensity conditioning (RIC) and high-intensity conditioning (HIC) regimens as well as human leukocyte antigen (HLA)-matched and HLA-mismatched grafts.